IPO Lisboa FG, EPE /ID# 225072

Lisbon 1099-023

0 studies enrolling now · 1 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Cancer, Chronic Lymphocytic Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma

Studies at this site

• An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial — Running, not enrolling